EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure

Jing Dong, Tianhao Shi, Bingbiao Lin, Xuetong Liu, Waner Wei, Zichi Geng, Mingcheng Liu, Renhong Yan iD, Jin-Tang Dong iD

Protein & Cell · 2025

DOI: 10.1093/procel/pwaf076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Jing Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Cell Biology and Genetics, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technol…. Hauptthemen laut MEDLINE: Breast Neoplasms, Amino Acid Transport System y+, Amino Acid Transport Systems, Basic. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a prevalent malignancy worldwide. The majority of breast cancers belong to the estrogen receptor (ER)-positive luminal subtype that can be effectively treated with antiestrogen therapies. However, a significant portion of such malignancies become hormone-refractory and incurable. Cancer cells often uptake more cystines to increase glutathione (GSH) biosynthesis and reduce reactive oxygen species (ROS), thereby preventing ROS-induced ferroptosis and leading to therapeutic resistance. However, few molecules of these processes are targetable for cancer therapy. However, few therapeutic targets have been established that target these processes. Here, we report that the gene for SLC7A13, a member of the SLC7A13-SLC3A1 cystine transporter, was amplified and overexpressed in 19.7% and 49.7% of breast cancers, respectively. SLC7A13 amplification and overexpression were associated with worse overall survival and disease-free survival in patients with luminal breast cancer. Functionally, SLC7A13 overexpression promoted, while its silencing attenuated, cell survival or proliferation. Molecularly, SLC7A13 silencing reduced cystine uptake and GSH biosynthesis, leading to increased lipid ROS levels. The cryo-EM structure of the human SLC7A13-SLC3A1 complex was determined at 2.64 Å, revealing a dimer-of-heterodimers architecture similar to that of other SLC3A1-linked transporters. A specific substrate-binding pocket was identified, containing distinct residues, which suggests a regulatory role in the cystine transporter. These findings suggest that the SLC7A13-SLC3A1 cystine transporter is a therapeutic target for treating luminal breast cancer. They also provide the structural insights for therapeutic development targeting the cystine transporter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAmino Acid Transport System y+Amino Acid Transport Systems, BasicHumansFemaleCryoelectron MicroscopyCystineCell Line, TumorReactive Oxygen SpeciesAmino Acid Transport Systems, Neutral

Stichwörter der Autor:innen

SLC7A13breast cancercryo-EMcystine transporterferroptosis

Substanzen

Amino Acid Transport System y+SLC3A1 protein, humanCystineAmino Acid Transport Systems, BasicReactive Oxygen SpeciesAmino Acid Transport Systems, Neutral

Autor:innen und Institutionen

  • Department of Human Cell Biology and Genetics, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
  • Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Key University Laboratory of Metabolism and Health of Guangdong, Institute for Biological Electron Microscopy, Southern University…
  • Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou 518055, China.

ORCID-Profile: Renhong Yan, Jin-Tang Dong

Förderung

  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Guangdong Province
  • Major Talent Recruitment Program of Guangdong Province

Zitieren

APA

Dong, J., Shi, T., Lin, B., Liu, X., Wei, W., Geng, Z., Liu, M., Yan, R., & Dong, J. T. (2025). Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure. Protein & Cell. https://doi.org/10.1093/procel/pwaf076

Vancouver

Dong J, Shi T, Lin B, Liu X, Wei W, Geng Z, et al. Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure. Protein & Cell. 2025. doi:10.1093/procel/pwaf076

BibTeX
@article{Dong2025,
  author = {Dong, Jing and Shi, Tianhao and Lin, Bingbiao and Liu, Xuetong and Wei, Waner and Geng, Zichi and Liu, Mingcheng and Yan, Renhong and Dong, Jin-Tang},
  title = {Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure},
  journal = {Protein & Cell},
  year = {2025},
  doi = {10.1093/procel/pwaf076}
}
Kostenlos starten →